Skip to main content
Premium Trial:

Request an Annual Quote

European Research Consortium Receives $1.6M from EU to Develop Array-Based Sequencing Technology

NEW YORK, Aug. 26 (GenomeWeb News) - A consortium of European companies and research institutions has received $1.6 million in funding from the European Commission to develop an array-based sequencing-by-synthesis technology from Quiatech, the Uppsala, Sweden-based company said on Wednesday.

 

Quiatech, as the project coordinator, will be responsible for dispersing the funds, according to Torbjorn Pettersson, a company spokesperson.

 

Besides Quiatech, members of the consortium are Asper Biotech of Tartu, Estonia; Fermentas of Vilnius, Lithuania; the University of Frankfurt in Germany, Tartu University in Estonia, and Silex Microsystems of Järfälla, Sweden.

 

The aim of the two-year project, to commence at the end of August, is to develop an array platform with thousands of oligonucleotide features for sequencing by synthesis. In a second phase, for which they may involve additional partners, the members plan to commercialize the resulting technology.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.